Skip to main content
Premium Trial:

Request an Annual Quote

IP Update: Recent Patents Awarded to Novozymes, University of Texas, and More


Title: Methods for Eliminating or Reducing the Expression of a Gene in a Filamentous Fungal Strain

Patent Number: 8,716,023

Filed: Dec. 9, 2004

Lead Inventor: Howard Brody, Novozymes

Title: microRNA Compositions and Methods for the Treatment of Myelogenous Leukemia

Patent Number: 8,716,255

Filed: Aug. 11, 2008

Lead Inventor: Florian Kuchenbauer, British Columbia Cancer Agency

Title: Compositions and Methods for Silencing Ebola Virus Gene Expression

Patent Number: 8,716,464

Filed: July 20, 2010

Lead Inventor: Thomas Geisbert, University of Texas Medical Branch (Tekmira Pharmaceuticals)

Title: Kit for Making Induced Pluripotent Stem Cells using Modified RNAs

Patent Number: 8,716,465

Filed: Aug. 21, 2012

Lead Inventor: Derrick Rossi, Children's Medical Center

Title: microRNAs for Identification of Exposure to Lower Aliphatic Saturated Aldehydes and the Method of Identification using Thereof

Patent Number: 8,716,192

Filed: Nov. 29, 2012

Lead Inventor: Jae Chun Ryu, Korea Institute of Science and Technology

Title: Regulation of Metabolism by miR-378

Patent Number: 8,716,258

Filed: June 6, 2011

Lead Inventor: Eric Olson, University of Texas